NEW YORK (AP) -- Teva Pharmaceutical Industries Ltd. on Wednesday disclosed a recall it began in October of 75 bottles of antibacterial tablets known as metronidazole.
Teva said it already has gotten back 50 of the affected bottles, which contain about 250 tablets each of 250-millgram metronidazole tablets. It recalled the medication because some of the tablets in the affected lot are underweight and may not deliver a full dose, and that could cause an infection to get worse or recur, the company said.
Metronidazole is used to treat bacterial infections including trichomoniasis, a sexually transmitted disease, and amebiasis, which affects the intestines.
Consumers are advised to stop using metronidazole tablets that come from production lot 312566.
Teva said it has not learned of any side effects associated with the underweight tablets.
It said the product was shipped in October 2009 and expires May 2012, and it notified wholesalers and retailers of the problem in October.
Shares of Teva Pharmaceuticals fell 41 cents to $52.11 on Wednesday. The stock was unchanged in aftermarket trading.
Teva said it already has gotten back 50 of the affected bottles, which contain about 250 tablets each of 250-millgram metronidazole tablets. It recalled the medication because some of the tablets in the affected lot are underweight and may not deliver a full dose, and that could cause an infection to get worse or recur, the company said.
Metronidazole is used to treat bacterial infections including trichomoniasis, a sexually transmitted disease, and amebiasis, which affects the intestines.
Consumers are advised to stop using metronidazole tablets that come from production lot 312566.
Teva said it has not learned of any side effects associated with the underweight tablets.
It said the product was shipped in October 2009 and expires May 2012, and it notified wholesalers and retailers of the problem in October.
Shares of Teva Pharmaceuticals fell 41 cents to $52.11 on Wednesday. The stock was unchanged in aftermarket trading.
